GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Momentum Rank

APLIF (Appili Therapeutics) Momentum Rank : 0 (As of Dec. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Momentum Rank?

Appili Therapeutics has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Appili Therapeutics Momentum Rank Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Momentum Rank
Comparable Companies
TSXV:RP XCNQ:MESC TSXV:IOT TSXV:RKV XCNQ:MBIO XCNQ:BRAX XCNQ:NOVA XCNQ:BIOV XCNQ:GLOW XCNQ:BETR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
APLI:Canada
Address
1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Website
https://www.appilitherapeutics.com
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.